Reformulating the Future of Small Molecules
A special collection of recent stories exploring oral dose innovation, API stability, nitrosamine testing, and the evolving science of small molecule medicines
False
A special collection of recent stories exploring oral dose innovation, API stability, nitrosamine testing, and the evolving science of small molecule medicines
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
False
False
July 27, 2026
3 min read
AI can help formulation teams better predict performance and allocate resources, but proprietary data protections remain a critical bottleneck
July 21, 2026
4 min read
John McDermott reflects on why early drug development remains fragmented – and how integrated approaches may shorten timelines
July 13, 2026
6 min read
How targeted in vivo CAR T delivery could pave the way for autoimmune disease treatments
June 30, 2026
1 min read
A special collection of recent stories exploring oral dose innovation, API stability, nitrosamine testing, and the evolving science of small molecule medicines
False
Affiliations:
Specialties:
Areas of Expertise: